Protein analysis company ProteinSimple files for a $86 million IPO
ProteinSimple, which develops systems for protein analysis, filed on Thursday with the SEC to raise up to $86 million in an initial public offering. The Santa Clara, CA-based company, which was founded in 2000 and booked $54 million in sales for the 12 months ended March 31, 2014, plans to list on the NASDAQ under the symbol PRTN. J.P. Morgan and BofA Merrill Lynch are the joint bookrunners on the deal. No pricing terms were disclosed.